Another Multi-Billion Dollar Settlement – JPMorgan Chase Agrees To Pay $13 Billion

Posted On Wednesday, November 20, 2013

JPMorgan Chase has agreed to pay $13 billion to resolve investigations into its involvement with the subprime mortgage investments which helped trigger the 2008 financial crisis.  Of this amount, $9 billion will go towards civil claims brought in federal and state courts while $4 billion will be aimed at helping consumers who were harmed by the improper mortgage conduct of JPMorgan and two of its subsidiaries – Bear Stearns and Washington Mutual.  Among the forms this assistance will take is loan forgiveness, loan modifications and efforts to reduce blight.  The monies to be paid under the settlement represent more than half of the profit JPMorgan reported in 2012. 

As part of the settlement, JPMorgan admitted that it knew that the residential mortgage-backed securities it was selling didn’t comply with underwriting guidelines and shouldn’t have been sold. 

U.S. Attorney General Eric Holder stated, “[w]ithout a doubt, the conduct uncovered in this investigation helped sow the seeds of the mortgage meltdown” and that “JPMorgan was not the only financial institution during this period to knowingly bundle toxic loans and sell them to unsuspecting investors, but that is no excuse for the firm’s behavior.”  According to JPMorgan CEO, Jamie Dimon, most of the improper mortgage conduct occurred at Bear Stearns and Washington Mutual.

While this settlement resolves certain civil claims which had been brought against JPMorgan, the company and its officials can still be subject to criminal charges.  JPMorgan has denied violating any laws. 

Johnson & Johnson To Pay $2.2 Billion – That’s With A B!

Posted On Tuesday, November 5, 2013

On November 4, 2013, Attorney General Eric Holder, flanked by top brass from Main Justice, the Eastern District of Pennsylvania, the District of Massachusetts, and the Northern District of California announced a historic settlement by Johnson & Johnson of $2.2 billion related to criminal and civil allegations of off-label marketing of medication and kickbacks to physicians for prescribing these medications.  This settlement, paid by this corporate giant and three of its subsidiaries, relates to antipsychotic drugs Risperdal and Invega, as well as Natrecor – a cardiac medication.

This settlement was many years in the making, with allegations first brought to the government by whistleblowers under the qui tam provision of the False Claims Act (31 U.S.C. 3729, et seq.).  Off-label promotion of medications includes marketing the products for uses other than those approved by the U.S. Food and Drug Administration.  Not only does this practice place patients at risk, but it taints prescriptions written by physicians for these medications and results in improper payments by Medicare and Medicaid.  Attorney General Holder also credited the Department’s , also known as “HEAT” with relentless investigative and enforcement efforts.

For a full transcript of Attorney General Holder’s remarks, visit http://www.justice.gov/iso/opa/ag/speeches/2013/ag-speech-131104.html

Categories